Stay ahead in diagnostics with this course tailored for manufacturers, laboratories, and regulatory professionals. Discover the FDA’s class II classification and special controls for anti-phospholipase A2 receptor immunological test systems. Learn precisely what design, validation, labeling, and documentation standards must be met for compliance, and the real-world consequences of missing the mark. This training demystifies the De Novo pathway and clarifies the steps required to market innovative immunology devices while maintaining FDA standards.
In this course you will learn the following:
* Understand the FDA’s classification process for new medical devices, specifically the De Novo pathway.
* Identify the key requirements and special controls for the anti-phospholipase A2 receptor immunological test system.
* Implement the necessary steps to ensure compliance with the new classification and labeling requirements.
* Recognize the legal and regulatory consequences of failing to comply with the final rule.
